# Curie.Bio

> Biotech accelerator and VC pairing seed capital with drug-discovery co-pilot services for pre–Series A therapeutics.

## Why it is interesting

Curie.Bio is itself a fund/platform — a16z and ARCH co-back the vehicle that writes $5–15M seed checks and runs vendor-heavy R&D ops for founders.

## Profile

- **Stage:** other
- **Status:** private
- **Industries:** biotech-life-sciences, healthtech
- **Coverage:** full
- **Last updated:** 2026-07-24

## Key facts

- Launch (2022): $520M across seed + services vehicles; backers include ARCH Venture Partners, GV, and a16z (Fierce Biotech)
- Seed fund (Jan 2025): +$340M to invest in 15–25 therapeutics startups/year (STAT)

## Investors in our directory

- https://venturecapitaltracker.com/fund/andreessen-horowitz
- https://venturecapitaltracker.com/fund/arch-venture-partners

---
Source: https://venturecapitaltracker.com/startup/curiebio